J&J names successor to CEO
NEW BRUNSWICK, N.J. — Johnson & Johnson on Tuesday named Alex Gorsky CEO of the company, effective April 26, the date of the company’s annual meeting of shareholders. Gorsky also has been nominated for election to the board of directors at the meeting.
Gorsky, 51, currently vice chairman of the company’s executive committee with responsibility for the medical devices and diagnostics group, global supply chain, healthcare compliance, and privacy and government affairs and policy, succeeds Bill Weldon, who has served as chairman and CEO of Johnson & Johnson since 2002. Weldon remains chairman.
As CEO, Gorsky will assume full management responsibilities for Johnson & Johnson, including those currently reporting to him and to Weldon. As vice chairman of the executive committee, Sheri McCoy will report to Gorsky when he assumes the role of CEO. She will continue to lead the pharmaceuticals and consumer groups, and maintain responsibility for information technology.
“This succession decision involved a rigorous, thorough and formal multi-year process, which included consideration of two superbly qualified internal candidates, as well as outside candidates," Weldon stated.
Jim Cullen, the independent presiding director of the Board of Directors, added: “It is a testament to the leadership development and succession planning process at Johnson & Johnson that Mr. Gorsky, like all of the previous chief executives in the Company’s 126-year history, was appointed from within the organization.”
Gorsky began his Johnson & Johnson career in 1988 as a sales representative with Janssen Pharmaceutica. Over the next 15 years, he advanced through positions of increasing responsibility in sales, marketing and management. In 2001, he was appointed president of Janssen, and in 2003, promoted to company group chairman of Johnson & Johnson’s pharmaceuticals business in Europe, the Middle East and Africa.
He left the company in 2004 to join the Novartis Pharmaceuticals Corporation, where he served as head of the company’s pharmaceuticals business in North America. Four years later, he returned to Johnson & Johnson as company group chairman and worldwide franchise chairman for Ethicon in the medical devices business. In 2009, he was appointed worldwide chairman of the surgical care group and to the Johnson & Johnson executive committee. He was appointed vice chairman of the executive committee in January 2011.
Gorsky holds a Bachelor of Science degree from the U.S. Military Academy at West Point, and spent six years in the U.S. Army. In 1996, he earned a Master of Business Administration degree from the Wharton School of the University of Pennsylvania.
Axe unleashes Anarchy
LONDON — A decade ago, Unilever’s Axe revolutionized the American grooming industry with its launch and has since become a leading men’s grooming brand. Now the brand is aiming to make history again with its first-ever fragrance for her. Enter Anarchy.
Anarchy For Him and For Her are the first-ever pair of body sprays to launch at the same time at mass. Time will tell just how girls will receive Anarchy for Her, but the brand already has a strong female following. Of the more than 2 million fans on Facebook in the United States alone, about a quarter of them are female.
Young men boost grooming sales
Men’s body grooming has grown in popularity, especially among the younger generation, resulting in growth in the men’s grooming/shaving scissors segment at mass. According to data from SymphonyIRI Group, the category grew nearly 26% to more than $103 million for the 12 weeks ended Jan. 22 at food, drug and mass (excluding Walmart). The segment will likely continue to grow as manufacturers develop new innovative products, such as Clio Designs’ Hypergroom Body Groomer, a triple blade, battery-operated body groomer.
The article above is part of the DSN Category Review Series. For the complete Men’s Grooming Sell-Through Report, including extensive charts, data and more analysis, click here.